Clinical and Biochemical Features in a Case of Familial Hypocalciuric Hypercalcemia Type 3 with AP2S1 Gene Mutation in Codon Arg15His
Familial hypocalciuric hypercalcemia (FHH) is usually a benign condition divided into three types. FHH-3 occurs in about 20% of the cases and is caused due to missense mutations in AP2S1 (adaptor-related protein complex 2 subunit sigma 1) involving the codon Arg15 (p.R15). We report a case of FHH-3...
Main Authors: | Mohamed Aashiq, Asma Jassim Malallah, Farheen Khan, Maryam Alsada |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2020-01-01
|
Series: | Case Reports in Pediatrics |
Online Access: | http://dx.doi.org/10.1155/2020/7312894 |
Similar Items
-
Utility of cinacalcet in familial hypocalciuric hypercalcemia
by: Bipin Kumar Sethi, et al.
Published: (2017-01-01) -
Familial Hypocalciuric Hypercalcemia in Pregnancy: Diagnostic Pitfalls
by: Alicia R Jones, et al.
Published: (2020-06-01) -
Clinical and biochemical outcomes of cinacalcet treatment of familial hypocalciuric hypercalcemia: a case series
by: Rasmussen Anne, et al.
Published: (2011-12-01) -
A rare cause of hypercalcemia presenting with high parathormone levels: Familial hypocalciuric hypercalcemia
by: Okan Bakiner, et al.
Published: (2013-08-01) -
Collision Diagnoses: Primary Hyperparathyroidism Layered on Familial Hypocalciuric Hypercalcemia
by: Seth Kay, MD, et al.
Published: (2018-09-01)